scholarly journals Oral acyclovir (Zovirax) in herpes simplex dendritic corneal ulceration.

1986 ◽  
Vol 70 (6) ◽  
pp. 435-438 ◽  
Author(s):  
L. M. Collum ◽  
P. McGettrick ◽  
J. Akhtar ◽  
J. Lavin ◽  
P. J. Rees
Keyword(s):  
Herpes Simplex ◽  
Oral Acyclovir ◽  
Corneal Ulceration

scholarly journals Randomised double-blind trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex amoeboid corneal ulceration.

1985 ◽  
Vol 69 (11) ◽  
pp. 847-850 ◽  
Author(s):  
L M Collum ◽  
P Logan ◽  
D McAuliffe-Curtin ◽  
S O Hung ◽  
A Patterson ◽  
...  
Keyword(s):  
Herpes Simplex ◽  
Double Blind Trial ◽  
Corneal Ulceration ◽  
Double Blind ◽  
Blind Trial ◽  
Adenine Arabinoside

▾Oral acyclovir for herpes zoster

1988 ◽  
Vol 26 (24) ◽  
pp. 93-94
Keyword(s):  
Herpes Zoster ◽  
Herpes Simplex ◽  
Intravenous Infusion ◽  
Oral Acyclovir ◽  
Alternative Treatments ◽  
Varicella Zoster

In 1984 we hailed acyclovir (ACV; Zovirax - Wellcome) as an advance in the treatment of herpes simplex and varicella zoster infections.1 Most trials showing its value in zoster involved intravenous infusion in hospital, yet most patients would not otherwise need admission. Oral ACV is now vigorously promoted “to quench the fire of shingles” in the community. At least 20% of adults have zoster at some time, and most recover spontaneously. How does oral ACV compare with alternative treatments for zoster, and when is it worth using?

Sign in / Sign up

Export Citation Format

Share Document